Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
Feb 08,2024
Medlab Dubai 2024
Nov 14,2023
The first day of MEDICA 2023 is coming
Aug 08,2019
On December 27, 2019, Guangdong Weishi Biotechnology Co., Ltd. was officially established.
Aug 14,2020
In 2020, the new crown virus test kit entered the white list of epidemic prevention medical materials of the Ministry of Commerce and ISO13485 the quality management system certification.
Aug 14,2021
2021 Debuts CACLP, Releases Handheld Colloidal Gold/Fluorescence Immunoanalyzer
Aug 14,2022
2022 "only" innovation, win the future! Only real new products unveiled 2022 Germany MEDICA medical exhibition
Aug 14,2023
In 2023, the multi-channel immunofluorescence analyzer was officially launched and received wide acclaim in the industry.
May 13,2020
WESAIL Participated in Dongguan New Coronavirus Pneumonia Epidemic Prevention Research Project
As a partner of the project undertaking unit, WESAIL participated in the research and promotion of new coronavirus pneumonia epidemic prevention and control technology in Dongguan City, and was responsible for the research and development of new coronavirus immune POCT reagents. This project was initiated by the Dongguan Science and Technology Bureau, aiming to improve the ability of Dongguan City to prevent and control the epidemic, POCT reagent can quickly detect the new crown virus infection, help doctors quickly confirm the diagnosis, help the epidemic prevention and control.
May 15,2020
WESAIL Novel Coronavirus Detection Reagent Obtain CE Certificate
On May 15, 2020, the new coronavirus (COVID-19) IgM /IgG test kit developed and produced by Guangdong Weishi Biotechnology Co., Ltd. was awarded CE certification. As a safety certification mark, "CE" is regarded as a passport for manufacturers to open the European market. Getting CE certification means that the new coronavirus kit produced by Weishi can be sold in the European Union and other countries that recognize CE certification. This kit is suitable for the rapid detection of IgM/IgG antibody of novel coronavirus in human serum, plasma and whole blood.
Jun 17,2020
WESAIL Novel Coronavirus Detection Reagent Enters the White List of Epidemic Prevention Materials Export of the Ministry of Commerce
On June 17, 2020, the new coronavirus (COVID-19) IgM /IgG test kit developed and produced by Guangdong Weishi Biotechnology Co. As the testing reagents have obtained the EU CE certification, in accordance with the latest announcement requirements, only a written statement is submitted, promising that the products meet the quality standards and safety requirements of the customer's country, you can export the relevant epidemic prevention materials. The simplification of export procedures will facilitate the foreign sales of this new crown testing reagent and help the global war epidemic.